Physician profile
Jon Marks
NPI 1831124593
$1,275.21
in general payments reported to CMS, 2019-2025
20 companies · $265 in 2025
The $265 reported for 2025 was more than what 81% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $211 · 2020: $34.01 · 2021: $160 · 2022: $280 · 2023: $195 · 2024: $131 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $591.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $590.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $182.64 | 2021-2024 | Gardasil 9, Vaxneuvance, Vaxelis |
| Collegium Pharmaceutical, INC. | $154.71 | 2025 | Jornay Pm |
| Ironshore Pharmaceuticals INC. | $131.57 | 2019-2024 | |
| Corium, LLC | $127.89 | 2022-2025 | Azstarys |
| Kaleo, INC. | $106.19 | 2019-2022 | |
| Glaxosmithkline, LLC. | $99.27 | 2019-2024 | Bexsero, Rotarix |
| Cranial Technologies, INC | $74.15 | 2021-2023 | Doc Band |
| Seqirus USA INC | $74.15 | 2022-2024 | Flucelvax Quadrivalent, Flucelvax |
| Sanofi Pasteur INC. | $59.07 | 2019-2023 | |
| Pfizer INC. | $50.51 | 2019-2024 | |
| Qol Medical, LLC | $30.48 | 2021 | |
| Genentech USA, INC. | $27.45 | 2019 | |
| Ars Pharmaceuticals Operations, INC. | $24.52 | 2025 | Neffy |
| Takeda Pharmaceuticals U.S.A., INC. | $24.39 | 2020-2021 | |
| Shire North American Group INC | $23.82 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Welch Allyn | $21.95 | 2020 | |
| Travere Therapeutics, INC. | $19.33 | 2023 | Cholbam |
| Kyowa Kirin, INC. | $17.69 | 2025 | |
| Mission Pharmacal Company | $13.94 | 2019 | |
| Adlon Therapeutics L.P. | $11.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Marks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.